A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase
about
In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tractPhenylketonuria: a review of current and future treatmentsMicrobial enzymes: industrial progress in 21st centuryNew Strategies for the Treatment of Phenylketonuria (PKU)Discovery of Two Cyanobacterial Phenylalanine Ammonia Lyases: Kinetic and Structural Characterization † , ‡Structural and Biochemical Characterization of the Therapeutic Anabaena variabilis Phenylalanine Ammonia LyaseBiodegradation of aromatic compounds by Escherichia coliArtificial cell bioencapsulation in macro, micro, nano, and molecular dimensions: keynote lecturePhenylketonuria: old disease, new approach to treatment.Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKURecombinant proteins for genetic disease.Phenylalanine hydroxylase deficiency.Genetic and genomic systems to study methylmalonic acidemia.Phenylketonuria: an inborn error of phenylalanine metabolism.Artificial cells for replacement of metabolic organ functions.Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria.Up to date knowledge on different treatment strategies for phenylketonuria.State-of-the-art 2003 on PKU gene therapy.Artificial cells for cell and organ replacements.Therapeutic applications of polymeric artificial cells.Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuriaGene therapy for disorders affecting children, progress and potential.Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuriaProgress toward cell-directed therapy for phenylketonuria.The fate of intravenously administered tetrahydrobiopterin and its implications for heterologous gene therapy of phenylketonuria.Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria.Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria.Antioxidant treatment strategies for hyperphenylalaninemia.Biotechnological production and applications of microbial phenylalanine ammonia lyase: a recent review.Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives.Clinical therapeutics for phenylketonuria.Recombinant l-phenylalanine ammonia lyase from Rhodosporidium toruloides as a potential anticancer agent.Mannose 6-phosphate conjugation is not sufficient to allow induction of immune tolerance to phenylalanine ammonia-lyase in dogs.Biochemical Evaluation of Phenylalanine Ammonia Lyase from Endemic Plant Cyathobasis fruticulosa (Bunge) Aellen. for the Dietary Treatment of Phenylketonuria.Study on a novel strategy to treatment of phenylketonuria.Biopterin responsive phenylalanine hydroxylase deficiency.Structural basis for the entrance into the phenylpropanoid metabolism catalyzed by phenylalanine ammonia-lyase.Phenylketonuria: A new look at an old topic, advances in laboratory diagnosis, and therapeutic strategies.Quantitative bacterial micro-assay for rapid detection of serum phenylalanine on dry blood-spots: application in phenylketonuria screening.Descriptive and hedonic analyses of low-Phe food formulations containing corn (Zea mays) seedling roots: toward development of a dietary supplement for individuals with phenylketonuria.
P2860
Q24627253-7460C489-219E-4681-8454-977C7C259079Q26770291-28D9A73D-2518-4357-A4B8-B76DCE6B73DBQ26970832-A26B9555-1E88-483B-B2E7-E5C700A53459Q26999278-9493F876-85A5-4795-909C-63F04602FE87Q27641281-238AB9D8-A7A6-48BF-A9A2-F27B3DC2FCBDQ27650847-CCB8FB70-CC25-48D7-8AFB-79BC0D08323BQ28208239-41105F45-E90D-4219-B65D-B7F5B4E34805Q28251032-5471B27F-F6B4-45BE-B4EF-E4A1959AAEBDQ33537485-6C20E4F6-BCE2-40CB-A800-39C292EF45C5Q33698843-7118FAB4-DF35-4807-8D45-F3AE1BEAAE16Q33713530-1FE06810-861B-45ED-AABD-8484E202CC66Q34183829-3EE8AF14-C59A-4048-BFF3-2DE64DF24794Q34453620-431FED91-3080-430D-B320-D04B09DA003EQ34787712-80E7F669-422D-4579-A1A5-7C6DDA174827Q35129286-EFFD7343-694B-4CE2-9600-A280E3D205EDQ35490408-D739B0A9-A105-4F5D-AC72-58E4D40C5535Q35623929-5EB2629A-2375-44AC-BA1F-1FC92804B3ABQ35631781-6A3B55FA-998B-458E-904F-82B47E8B5168Q35717682-664474A4-3C7B-488B-8E3B-060E1703294AQ36058455-776D812C-3AC2-4574-AB1E-814EC04AB96DQ36304253-29D78D98-5C6D-4FBF-9247-739F5E46B457Q36816069-2AD898F2-7961-4B26-A4B9-B582F7780628Q37081629-AA27B633-AE30-4A13-87DE-CE8EA2706315Q37170974-092182F0-D643-49B1-82E9-C0A117556596Q37221639-CB15A634-9976-406E-AFFB-CDF229B50348Q37480507-14410922-80DA-4E04-8E9C-894F11F23907Q38096351-6CF0D045-4A36-4862-AB53-1B1D86A9F16EQ38105266-5BFF6325-E6F2-45DF-BDC9-2D5EF5A1208CQ38107989-C9E52A24-D1AE-4131-BB5B-BD080CAA0514Q38159436-7C2D898A-78A5-4EDD-84BC-7790B8405C4AQ38383086-EA5F2365-8EC8-478D-8A07-1B1061F6FF61Q39146109-69D80D5C-7FD7-48ED-81A5-E2298FDDECFEQ42257752-B65152A0-8C49-4227-A704-E0F26D61BD61Q42354366-436A5E21-DB1E-4432-AECA-F87A855B3F7DQ44134678-0E21B332-C604-40A2-9C0A-9F2A7E887E8EQ44730873-316B71CB-78A8-4D2D-93E9-9374E1387FD9Q45153599-95C80F34-4986-423F-87F4-51485A0EFCA9Q45874121-B5D1C791-1E93-4F82-9612-1CFFB18D7474Q46866313-BAFCDC6F-CEEC-4352-80CC-2F2F26FDE119Q50218729-CB8155B9-3D72-4EEC-AA8A-FBF740B64A18
P2860
A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A different approach to treatm ...... nt phenylalanine ammonia lyase
@ast
A different approach to treatm ...... nt phenylalanine ammonia lyase
@en
A different approach to treatm ...... nt phenylalanine ammonia lyase
@nl
type
label
A different approach to treatm ...... nt phenylalanine ammonia lyase
@ast
A different approach to treatm ...... nt phenylalanine ammonia lyase
@en
A different approach to treatm ...... nt phenylalanine ammonia lyase
@nl
prefLabel
A different approach to treatm ...... nt phenylalanine ammonia lyase
@ast
A different approach to treatm ...... nt phenylalanine ammonia lyase
@en
A different approach to treatm ...... nt phenylalanine ammonia lyase
@nl
P2093
P2860
P3181
P356
P1476
A different approach to treatm ...... nt phenylalanine ammonia lyase
@en
P2093
C N Sarkissian
C R Scriver
P2860
P304
P3181
P356
10.1073/PNAS.96.5.2339
P407
P577
1999-03-02T00:00:00Z